• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病疾病中的挑战与机遇:对未来的综合展望

Challenges and Opportunities in Psoriatic Disease: An Integrated View of the Future.

作者信息

Chinchay Lyn, Song Kaiyang, Stark Jeffrey, Ward Nicole L, McInnes Iain B

机构信息

L. Chinchay, MD, MS, Department of Rheumatology, Carita Feliz Clinic, Piura, Peru.

K. Song, BMBCh, Academic Foundation Doctor, Guy's and St Thomas' NHS Foundation Trust, London, UK.

出版信息

J Rheumatol. 2025 Aug 5. doi: 10.3899/jrheum.2025-0264.

DOI:10.3899/jrheum.2025-0264
PMID:40763948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12331142/
Abstract

Psoriatic disease (PsD), which includes cutaneous psoriasis (PsO) and psoriatic arthritis (PsA), affects 2% of the global population, and results in the development of comorbidities that adversely affect quality of life (QOL) and physical function. Recent advances in the field have allowed for earlier diagnosis of PsD and improved clinical strategies for care, including the use of innovative pathway-specific immune-targeted therapies. Despite these advances, there is no cure for PsD. Ongoing challenges in disease management include the need for adequate treatment response, precision-based care for individual patients, and a better understanding of the interrelationship between the pathogenesis of cutaneous PsO and PsO comorbidities, including PsA. Future progress may arise from integrating clinical disciplines, harnessing artificial intelligence, using molecular dissection to map out the disease pathogenesis of PsA to identify more effective treatment strategies, and exploring the interplay between PsD and comorbidities including cardiovascular disease, obesity, and depression. These developments could lead to personalized treatment approaches and increase the efficacy of therapeutics for PsD, ultimately improving patient outcomes and QOL. This article highlights the presentation of this topic at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting.

摘要

银屑病(PsD)包括皮肤银屑病(PsO)和银屑病关节炎(PsA),影响全球2%的人口,并导致出现对生活质量(QOL)和身体功能产生不利影响的合并症。该领域的最新进展使得能够更早地诊断银屑病,并改进了临床护理策略,包括使用创新的针对特定通路的免疫靶向疗法。尽管有这些进展,但银屑病仍无法治愈。疾病管理中持续存在的挑战包括需要有足够的治疗反应、针对个体患者的精准护理,以及更好地理解皮肤银屑病和银屑病合并症(包括银屑病关节炎)发病机制之间的相互关系。未来的进展可能源于整合临床学科、利用人工智能、使用分子剖析来绘制银屑病关节炎的疾病发病机制以确定更有效的治疗策略,以及探索银屑病与包括心血管疾病、肥胖症和抑郁症在内的合并症之间的相互作用。这些进展可能会带来个性化的治疗方法,并提高银屑病治疗的疗效,最终改善患者的治疗效果和生活质量。本文重点介绍了该主题在银屑病和银屑病关节炎研究与评估小组(GRAPPA)2024年年会上的展示情况。

相似文献

1
Challenges and Opportunities in Psoriatic Disease: An Integrated View of the Future.银屑病疾病中的挑战与机遇:对未来的综合展望
J Rheumatol. 2025 Aug 5. doi: 10.3899/jrheum.2025-0264.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.依那西普和英夫利昔单抗治疗银屑病关节炎:系统评价与经济学评估
Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. doi: 10.3310/hta10310.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
7
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease.银屑病疾病成像与治疗策略中的精准医学进展。
Autoimmun Rev. 2025 Jul 31;24(8):103839. doi: 10.1016/j.autrev.2025.103839. Epub 2025 May 31.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2025 Aug 6;8(8):CD011535. doi: 10.1002/14651858.CD011535.pub7.
9
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

本文引用的文献

1
Advancing Psoriasis Care through Artificial Intelligence: A Comprehensive Review.通过人工智能推进银屑病护理:全面综述
Curr Dermatol Rep. 2024 Sep;13(3):141-147. doi: 10.1007/s13671-024-00434-y. Epub 2024 Jun 13.
2
Predicting psoriasis severity using machine learning: a systematic review.使用机器学习预测银屑病严重程度:一项系统综述。
Clin Exp Dermatol. 2025 Feb 24;50(3):520-528. doi: 10.1093/ced/llae348.
3
Axial Disease in Psoriatic Arthritis: A Challenging Domain in Clinical Practice.银屑病关节炎的中轴型疾病:临床实践中的一个具有挑战性的领域。
Diagnostics (Basel). 2024 Jul 30;14(15):1637. doi: 10.3390/diagnostics14151637.
4
Benchmarking clustering, alignment, and integration methods for spatial transcriptomics.对空间转录组学的聚类、比对和整合方法进行基准测试。
Genome Biol. 2024 Aug 9;25(1):212. doi: 10.1186/s13059-024-03361-0.
5
Paradoxical psoriasis with IL-17 inhibitors.伴有白细胞介素-17抑制剂的矛盾性银屑病。
Rheumatol Adv Pract. 2024 Jul 9;8(3):rkae082. doi: 10.1093/rap/rkae082. eCollection 2024.
6
Graph machine learning for integrated multi-omics analysis.图机器学习在整合多组学分析中的应用。
Br J Cancer. 2024 Jul;131(2):205-211. doi: 10.1038/s41416-024-02706-7. Epub 2024 May 10.
7
Single Cell Atlas: a single-cell multi-omics human cell encyclopedia.单细胞图谱:单细胞多组学人类细胞百科全书。
Genome Biol. 2024 Apr 19;25(1):104. doi: 10.1186/s13059-024-03246-2.
8
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.EULAR 推荐的药物治疗银屑病关节炎管理:2023 更新。
Ann Rheum Dis. 2024 May 15;83(6):706-719. doi: 10.1136/ard-2024-225531.
9
Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade.银屑病消退的单细胞分析表明,IL-23 阻断靶向炎症性成纤维细胞状态。
Nat Commun. 2024 Jan 30;15(1):913. doi: 10.1038/s41467-024-44994-w.
10
Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow.难治性银屑病关节炎:走出类风湿关节炎的阴影。
Nat Rev Rheumatol. 2024 Mar;20(3):135-136. doi: 10.1038/s41584-024-01083-y.